Thursday, 10 December 2020

Insufficient screening for heart damage after noncardiac surgery puts patients at risk

About five percent of patients experience heart muscle injury around the time of their surgery for a noncardiac condition, yet guideline recommendations to identify patients at risk using biomarkers are not being followed. A five-year study in Alberta, Canada appearing in the Canadian Journal of Cardiology, determined that the recommended biomarker screening is very much underutilized.